Non-coding RNA therapeutics in the treatment of heart failure

被引：2
作者：
Paterek, Aleksandra [1 ]
Zaleska-Kociecka, Marta [2 ]
Surzykiewicz, Mateusz [1 ]
Wojdynska, Zuzanna [2 ]
Leszek, Przemyslaw [2 ]
Maczewski, Michal [1 ]
机构：
[1] Ctr Postgrad Med Educ, Dept Clin Physiol, Marymoncka 99-103, PL-01813 Warsaw, Poland
[2] Natl Inst Cardiol, Heart Failure & Transplantol Dept, Mech Circulatory Support & Transplant Dept, Alpejska 42, PL-04628 Warsaw, Poland
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2024年 / 10卷 / 04期
关键词：
Non-coding RNA; Heart failure; Therapy; Heart failure with reduced ejection fraction; MicroRNA; ANTISENSE OLIGONUCLEOTIDES; TARGETED DELIVERY; ANIMAL-MODEL; DOUBLE-BLIND; MICRORNAS; REVEALS; ANGIOTENSINOGEN; INTERFERENCE; HYPERTROPHY; SUPPRESSION;
D O I：
10.1093/ehjcvp/pvae027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Non-coding RNA (ncRNA) therapeutics can target either ncRNAs or conventional messenger RNA, offering both superior pharmacokinetics and selectivity to conventional therapies and addressing new, previously unexplored pathways. Although no ncRNA has yet been approved for the treatment of heart failure, in this review we present five most promising pathways and agents that either are in human clinical trials or offer great promise in the near future.
引用
收藏
页码：353 / 360
页数：8
相关论文
共 76 条
  • [1] Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study
    Abplanalp, Wesley Tyler
    Fischer, Ariane
    John, David
    Zeiher, Andreas M.
    Gosgnach, Willy
    Darville, Helene
    Montgomery, Rusty
    Pestano, Linda
    Allee, Guillaume
    Paty, Isabelle
    Fougerousse, Francoise
    Dimmeler, Stefanie
    [J]. NUCLEIC ACID THERAPEUTICS, 2020, 30 (06) : 335 - 345
  • [2] Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature
    Adam, Robert Daniel
    Coriu, Daniel
    Jercan, Andreea
    Badelita, Sorina
    Popescu, Bogdan A.
    Damy, Thibaud
    Jurcut, Ruxandra
    [J]. ESC HEART FAILURE, 2021, 8 (04): : 2380 - 2396
  • [3] The role of lipid components in lipid nanoparticles for vaccines and gene therapy
    Albertsen, Camilla Hald
    Kulkarni, Jayesh A.
    Witzigmann, Dominik
    Lind, Marianne
    Petersson, Karsten
    Simonsen, Jens B.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2022, 188
  • [4] Heidenreich Paul A, 2022, Circulation, V145, pe895, DOI [10.1161/CIR.0000000000001073, 10.1161/CIR.0000000000001063]
  • [5] PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy
    Ardite, Esther
    Perdiguero, Eusebio
    Vidal, Berta
    Gutarra, Susana
    Serrano, Antonio L.
    Munoz-Canoves, Pura
    [J]. JOURNAL OF CELL BIOLOGY, 2012, 196 (01) : 163 - 175
  • [6] The impact of microRNAs on protein output
    Baek, Daehyun
    Villen, Judit
    Shin, Chanseok
    Camargo, Fernando D.
    Gygi, Steven P.
    Bartel, David P.
    [J]. NATURE, 2008, 455 (7209) : 64 - U38
  • [7] CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure
    Batkai, Sandor
    Genschel, Celina
    Viereck, Janika
    Rump, Steffen
    Baer, Christian
    Borchert, Tobias
    Traxler, Denise
    Riesenhuber, Martin
    Spannbauer, Andreas
    Lukovic, Dominika
    Zlabinger, Katrin
    Hasimbegovic, Ena
    Winkler, Johannes
    Garamvolgyi, Rita
    Neitzel, Sonja
    Gyoengyoesi, Mariann
    Thum, Thomas
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (02) : 192 - 201
  • [8] Efficacy and Safety of miR-132 Inhibitor CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction: Rationale for and Design of the HFREVERT Trial
    Bauersachs, Johann K.
    Solomon, Scott
    Anker, Stefan D.
    Miranda, Maria Isabel Antorrena
    Batkai, Sandor
    Filippatos, Gerasimos
    Ponikowski, Piotr
    Vardeny, Orly
    Hauke, Wilfried
    Thum, Thomas
    [J]. CIRCULATION, 2023, 148
  • [9] miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents
    Baumann, Volker
    Winkler, Johannes
    [J]. FUTURE MEDICINAL CHEMISTRY, 2014, 6 (17) : 1967 - 1984
  • [10] Single Intracoronary Injection of Encapsulated Antagomir-92a Promotes Angiogenesis and Prevents Adverse Infarct Remodeling
    Bellera, Neus
    Barba, Ignasi
    Rodriguez-Sinovas, Antonio
    Ferret, Eulalia
    Angel Asin, Miguel
    Teresa Gonzalez-Alujas, Ma
    Perez-Rodon, Jordi
    Esteves, Marielle
    Fonseca, Carla
    Toran, Nuria
    Garcia del Blanco, Bruno
    Perez, Amadeo
    Garcia-Dorado, David
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (05):
12345678